Urmo Võsa (@Urmo1) profile picture

Researcher at Institute of Genomics, @unitartu

Tartu, Estonia
Joined May 2009
Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)Photo by Urmo Võsa (@Urmo1)
Hiring a PhD student! 🎓 PhD position on AI for predicting complex diseases using genetics, multi-omics & health records. Details and application info: genomics.ut.ee/en/content/ph…
2
6
435
Great news! Our Associate Professor of Neuropsychiatric Genomics, Kelli Lehto, has been selected to receive the European Research Council grant! 💐Congrats on that outstanding achievement! 👉ut.ee/en/news/erc-grant-help…
4
3
16
1,993
We are looking for a PhD student!🧬 📊 Research project: The role of exposome in the development of hypertension and its interactions with genetic risk 📍 Institute of Genomics, University of Tartu 📩 Application period: 1st–15th May 2025 More info: lnkd.in/daUUqujS
5
5
1,612
A great new resource for phenome-wide genetic explorations by the Estonian Biobank🇪🇪🧬 👉206,159 participants 👉GWASs for 4,884 ICD-10 diagnoses 👉2,127 unique GWAS loci 👉778 putatively novel locus-phenotype associations
1
12
70
6,227
New paper out: This is the largest genome-wide association study meta-analysis of its kind, analysing data on 42 female reproductive health diagnoses from the Estonian Biobank and FinnGen. See the study in Nature Medicine: nature.com/articles/s41591-0… @NatureMedicine
1
7
58
4,411
💡 New research highlight combines the data analyzed by Nightingale Health in @ESTbiobank and @uk_biobank: unlocking genetic links to metabolite traits in a groundbreaking genome-wide association study! Researchers in a recently published pre-print have conducted a comprehensive genome-wide association study (GWAS) on 249 circulating metabolite traits in over 619,000 individuals from the Estonian and UK Biobanks. The study identified 89,489 locus-metabolite pairs, of which 4,184 are novel associations. Importantly, 12.4% of lead variants were rare, highlighting the need to study low-frequency variants in metabolic biomarker research. This resource is a major step forward in understanding genetic contributions to disease risk and drug target discovery. Access the full preprint: medrxiv.org/content/10.1101/…
5
12
1,228
Happy to share our most recent GWAS meta-analysis of 249 circulating metabolic biomarkers (@NgaleHealth platform) in up to 619,372 individuals. medrxiv.org/content/10.1101/…
3
31
91
7,932
📢 GWAS meta-analysis preprint: - 249 circulating metabolite traits in over 600k individuals - Data from UKBB & EstBB, using Nightingale NMR - 4,184 novel loci (incl. results from non-EUR ancestries) - Loads of low frequency variants - Sumstats available on GWAS catalog FTP
Genome-wide association study for circulating metabolites in 619,372 individuals medrxiv.org/cgi/content/shor… #medRxiv
1
9
31
4,402
Genome-wide association study for circulating metabolites in 619,372 individuals medrxiv.org/cgi/content/shor… #medRxiv
7
2
29
9,429
The 23rd International Gene Forum 2024 will take place on September 24th – 25th, 2024 in Tartu, Estonia. The keynote speaker will be Stephen Kingsmore, president and CEO of @RadyGenomics. Read more about Gene Forum 2024 at geneforum.ee/
5
1
8
2,523
Krista Freeman and Kaur Alasoo show in LCLs that trans-eQTLs can be highly cell-type specific. We are happy to have contributed with eQTLGen phase 2: we replicated some of these, but with much smaller effect-sizes in blood.
1
6
10
1,566
"While much of Europe is obsessing over this year’s European Football Championships, many Estonians — whose team didn’t qualify — are absorbed in their own genomes." And they have pretty awesome genomes, I must say! Read the full story by @ewencallaway: nature.com/articles/d41586-0…
21
1
98
6,671
Robert Warmerdam will present his work today on eQTLGen phase 2 at the ASHG: a full trans-eQTL meta-analysis across many blood cohorts and ancestries. Should you be interested in already working with interim freezes of eQTLGen phase 2: please get in touch with us!
Interested in our latest genome-wide trans-eQTL meta-analysis in the #eQTLGen Consortium? Today, from 3-5 pm, I will be presenting interim results at #ASHG23. Interested in collaborating and joining eQTLGen? Come meet me at PB1093 or go to eqtlgen.org!
8
25
3,483
Interested in our latest genome-wide trans-eQTL meta-analysis in the #eQTLGen Consortium? Today, from 3-5 pm, I will be presenting interim results at #ASHG23. Interested in collaborating and joining eQTLGen? Come meet me at PB1093 or go to eqtlgen.org!
1
7
1
29
5,071
🔬Excited for the 22nd Gene Forum! 🧬 Join top scientists from Europe and the USA on 24-25 Aug 2023 to discuss advances in genetics. 🌐 Among others one of the special focus will be on hereditary muscle diseases. Read more ➡️ shorturl.at/qrGW1
6
6
473
Really exciting to have had the chance to present our newest work on eQTLGen at #ESHG2023 and having received the Fellowship of Excellence for early career scientists. Many thanks to especially @HarmJanWestra, @LudeFranke and @Urmo1 for their expertise making this work possible!
3
22
667
Today Robert Warmerdam at #ESHG2023 will present interim results of eQTLGen phase 2 (Clyde auditorium, 11.30 - 11.45): a genome-wide trans-eQTL analysis, with implications for many molecular QTL studies. Interested to join eQTLGen? Get in touch or go to eQTLGen.org
7
25
2,470
Attend an exciting workshop on AI & Machine Learning, co-led by: - Anders Dale of University of California, San Diego - Hafsteinn Einarsson of deCODE at #NSHGPM2023 workshop on Precision Medicine: The Bridge from Research to Healthcare. Learn more: nshg-pm2023.org/
14
1
7
1,693